Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals
PHASE1CompletedINTERVENTIONAL
Enrollment
26
Participants
Timeline
Start Date
Not specified
Conditions
HIV Infections
Interventions
DRUG
Interleukin-2, Polyethylene Glycolated
DRUG
Zidovudine
Trial Locations (1)
94305
Stanford Univ School of Medicine, Stanford
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00000664 - Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals | Biotech Hunter | Biotech Hunter